Mouse IL-19 Alexa Fluor® 594-conjugated Antibody Summary
IL-19 is observed.
Accession # Q8CJ70
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Preparation and Storage
Interleukin 19 (IL-19) is a member of the IL-10 family of cytokines (1). The IL-10 family is a class II alpha -helical collection of cytokines that contains two groups, a viral homolog and a cellular homolog group. Within the cellular homolog group, there are two additional groupings, one which uses IL-10 R2 as a signal transducing receptor (IL-10, IL-22 and IL-26), and one which uses IL-20 R2 as a signal transducing receptor (IL-19, IL-20 and IL-24) (2‑4). Mouse IL-19 is synthesized as a 176 amino acid (aa) precursor that contains a 24 aa signal sequence and a 152 aa mature region (5). Based on human studies, it is expected to be secreted as a glycosylated monomer, 35‑45 kDa in size (2, 6, 7). IL-19 is unusual in that it contains seven amphipathic helices (2, 4, 8). Mature mouse IL-19 shares 69% aa sequence identity with the mature human IL-19, and 85% and 68% aa identity to unpublished Genbank sequences for rat and canine IL-19, respectively. Although mouse IL-19 is active on human cells, human IL-19 is not active on mouse cells (5). IL-19 expression is limited to activated keratinocytes and monocytes, with a possible contribution from B cells (6, 9, 10). IL-19 binds a receptor complex consisting of the IL-20 receptor alpha (also known as IL-20 R1) and the IL-20 receptor beta (IL-20 R2) (3, 4, 11, 12). This receptor complex is also shared by IL-20 and IL-24. Notably, IL-19 is reported to actually bind to IL-20 R2, which is generally considered to be only the signal transducing receptor subunit (7, 13). Functionally, it has been reported that IL-19 both will and will not induce IL-6 and TNF production by monocytes (5, 14). It does, however, seem to drive T-helper cell differentiation towards a Th2 response, inducing both IL-10 and production of itself (5, 14, 15).
- Fickenscher, H. et al. (2002) Trends Immunol. 23:89.
- Pestka, S. et al. (2004) Annu. Rev. Immunol. 22:929.
- Zdanov (2004) Curr. Pharm. Des. 10:3873.
- Gallagher, G. et al. (2004) Int. Immunopathol. 4:615.
- Laio, Y.-C. et al. (2002) J. Immunol. 169:4288.
- Gallagher, G. et al. (2000) Genes Immun. 1:442.
- Pletnev, S. et al. (2003) Biochemistry 42:12617.
- Chang, C. et al. (2003) J. Biol. Chem. 278:3308.
- Romer, J. et al. (2003) J. Invest. Dermatol. 121:1306.
- Wolk, K. et al. (2002) J. Immunol. 168:5397.
- Dumoutier, L. et al. (2001) J. Immunol. 167:3545.
- Parrish-Novak, J. et al. (2002) J. Biol. Chem. 277:47517
- Preimel, D. and H. Sticht (2004) J. Mol. Model. 10:290.
- Jordan, W.J. et al. (2005) Eur. J. Immunol. 35:1576.
- Laio, S.-C. et al. (2004) J. Immunol. 173:6712.
Product Specific Notices
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Mouse IL-19 Alexa Fluor® 594-conjugated Antibody
There are currently no reviews for this product. Be the first to review Mouse IL-19 Alexa Fluor® 594-conjugated Antibody and earn rewards!
Have you used Mouse IL-19 Alexa Fluor® 594-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image